CRISPR Therapeutics
CRSP
#3177
Rank
$3.84 B
Marketcap
$45.15
Share price
-0.48%
Change (1 day)
4.85%
Change (1 year)

CRISPR Therapeutics (CRSP) - P/B ratio

P/B ratio as of October 2024 : 1.95

According to CRISPR Therapeutics's latest financial reports the company has a price-to-book ratio of 1.95.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

CRISPR Therapeutics - P/B ratio (from 2016 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-312.6455.63%
2022-12-311.70-29.79%
2021-12-312.42-63.11%
2020-12-316.5566.24%
2019-12-313.944.33%
2018-12-313.78-24.93%
2017-12-315.0345.27%
2016-12-313.46
2015-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio differencediff. Country
2.24 14.93%๐Ÿ‡บ๐Ÿ‡ธ USA